Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Workit Health's Online Treatment Addresses Rising Kratom and 7-OH Dependence


News provided by

Workit Health

Mar 30, 2026, 11:15 ET

Share this article

Share toX

Share this article

Share toX


Online, evidence-based treatment now available for individuals struggling with cravings, withdrawal, and dependence

ANN ARBOR, Mich., March 30, 2026 /PRNewswire-PRWeb/ -- Workit Health, one of the nation's most trusted providers of online addiction treatment, has announced that it now treats kratom use disorder. Individuals experiencing cravings, dependence, or withdrawal from kratom and 7-OH can now access discreet, evidence-based care from home through the Workit Health app.

Kratom, a plant native to Southeast Asia, has long been used for its complex effects. At lower doses, it may produce stimulant-like effects; at higher doses, it interacts with the brain in ways similar to opioids. In recent years, increasingly potent kratom-derived products—especially 7-hydroxymitragynine, commonly known as 7-OH—have fueled a growing public health concern.

"The good news is that buprenorphine, which is a remarkably safe and effective treatment for opioid use disorder, can also be used to treat kratom or 7-OH use disorder. We see more and more individuals in our program with this condition, and treatment can be life-saving."

Post this

"These products may be marketed for general wellness, energy, or mood benefits, or as a safe, 'natural' form of high," says Workit Health Chief Medical Officer Dr. Justin Coffey. "But there is no evidence-based indication for medical use of either kratom or 7-OH. These products are not currently regulated, so it is impossible for individuals to know what they are consuming, including their properties, side effects, or risks."

7-OH is a concentrated form of a compound found in the kratom leaf. It can be 15-40x as potent as leaf kratom, potentially leading to a higher risk of addiction. In July of 2025, the FDA took steps to restrict the availability of 7-OH. But leaf kratom remains unregulated by the FDA, allowing kratom products to contain unpredictable and undisclosed concentrations of the kratom plant. The FDA's actions reflect a broader wave of legislative and regulatory activity at state, county, and municipal levels addressing products containing kratom.

For many, the consequences arrive quickly.

"I was in quite a bit of pain when someone told me I should try this new, stronger kratom," one Workit Health member relates. "I stupidly believed that that's all that 7-OH was. I had no idea how addictive it can be. Boy, did I learn fast! By June, I was taking upwards of 240 mg of 7-OH per day. I tried to wean down on my own, but the withdrawals were so bad I couldn't function normally."

The use of kratom and 7-OH can cause withdrawal symptoms, mood swings, increased tolerance, cravings, and overdose. In severe cases, it has resulted in death. The US Poison Centers are tracking serious health effects after exposure to 7-OH.

The toll extends beyond individuals to families and communities.

"As my husband's dependence on kratom deepened, I saw the spark fade from his eyes," one woman shares. "At his lowest point, he contemplated suicide. He told me he felt trapped. He said the withdrawal made him feel like there was no escape, like the pain in his body and mind would never end."

That experience is increasingly common.

"In our experience, individuals with problematic use of kratom or 7-OH experience significant anxiety and agitation, in addition to other signs and symptoms of opioid use disorder," Dr. Coffey said. "The good news is that buprenorphine, which is a remarkably safe and effective treatment for opioid use disorder, can also be used to treat kratom or 7-OH use disorder. We see more and more individuals in our program with this condition, and treatment can be life-saving."

Via the Workit Health app, members can attend online appointments, connect with others in recovery, and receive prescriptions for medications to relieve the cravings and withdrawal symptoms that can take such a painful toll on the physical and mental health of those who use kratom.

Workit Health was founded in 2015. An early innovator of telehealth treatment for substance use disorders, the company offers programs to treat opioid, alcohol, and now kratom use disorders through an app-based platform. Workit's harm-reduction approach focuses on lowering barriers to care, reducing stigma, and supporting sustainable recovery.

About Workit Health

Founded in 2015 by two women in recovery, Workit Health has been addressing substance use disorders using a virtual-first model for nine years and has provided care for over 35,000 members. The Workit clinical program includes video visits with licensed clinicians, e-prescribing for substance use disorders and comorbid conditions, and psychosocial, therapeutic support. Workit's innovative technology removes barriers and expands access to evidence-based, person-centered treatment for people struggling with drugs and alcohol, improving outcomes and reducing costs.

More about Workit Health at: https://www.workithealth.com.

Media Contact

Jaclyn Jutras, Workit Health, 1 (734) 489-1624, [email protected], https://www.workithealth.com/

SOURCE Workit Health

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.